- Home
- SCPH vs LFVN Comparison
SCPH vs LFVN Comparison
Compare SCPH & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCPH
- LFVN
- Stock Information
- Founded
- SCPH 2013
- LFVN N/A
- Country
- SCPH United States
- LFVN United States
- Employees
- SCPH N/A
- LFVN N/A
- Industry
- SCPH Biotechnology: Pharmaceutical Preparations
- LFVN Biotechnology: Pharmaceutical Preparations
- Sector
- SCPH Health Care
- LFVN Health Care
- Exchange
- SCPH Nasdaq
- LFVN Nasdaq
- Market Cap
- SCPH 173.6M
- LFVN 162.9M
- IPO Year
- SCPH 2017
- LFVN N/A
- Fundamental
- Price
- SCPH $4.85
- LFVN $13.08
- Analyst Decision
- SCPH Strong Buy
- LFVN Strong Buy
- Analyst Count
- SCPH 3
- LFVN 2
- Target Price
- SCPH $14.00
- LFVN $30.50
- AVG Volume (30 Days)
- SCPH 322.0K
- LFVN 82.7K
- Earning Date
- SCPH 08-07-2025
- LFVN 09-04-2025
- Dividend Yield
- SCPH N/A
- LFVN 1.43%
- EPS Growth
- SCPH N/A
- LFVN 152.87
- EPS
- SCPH N/A
- LFVN 0.70
- Revenue
- SCPH $49,969,000.00
- LFVN $222,347,000.00
- Revenue This Year
- SCPH $108.95
- LFVN $17.36
- Revenue Next Year
- SCPH $73.83
- LFVN $9.60
- P/E Ratio
- SCPH N/A
- LFVN $18.67
- Revenue Growth
- SCPH 107.79
- LFVN 8.22
- 52 Week Low
- SCPH $1.94
- LFVN $7.09
- 52 Week High
- SCPH $6.28
- LFVN $27.38
- Technical
- Relative Strength Index (RSI)
- SCPH 51.56
- LFVN 48.87
- Support Level
- SCPH $4.33
- LFVN $12.07
- Resistance Level
- SCPH $4.82
- LFVN $14.08
- Average True Range (ATR)
- SCPH 0.35
- LFVN 0.70
- MACD
- SCPH -0.07
- LFVN -0.10
- Stochastic Oscillator
- SCPH 49.55
- LFVN 34.47
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.